NextPoint Presents B7-H7 Directed T Cell Engager at SITC 2024
07 Nov 2024 //
BUSINESSWIRE
NextPoint Announces New Drug Candidate NPX372 in Solid Tumors
05 Sep 2024 //
BUSINESSWIRE
NextPoint CEO Ivan Cheung On TIME100 Health List
06 May 2024 //
BUSINESSWIRE
NextPoint Announces First Patient Dosed in Phase 1a/b Clinical Trial of NPX267
17 Aug 2023 //
BUSINESSWIRE
Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors
21 Mar 2023 //
BUSINESSWIRE
NextPoint Announces $80M Series B Financing co-led by Leaps by Bayer and Sanofi
10 Jan 2023 //
BUSINESSWIRE